GeneFerm Biotechnology Co

GeneFerm Biotechnology Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of GeneFerm Biotechnology Co (1796.TWO) as of Oct 16, 2026 is 0.19.

PEG

0.19

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of GeneFerm Biotechnology Co is 2025 0.19 . PEG Ratio (Price/Earnings-to-Growth) of GeneFerm Biotechnology Co was 2024 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneFerm Biotechnology Co Stock analysis

What does GeneFerm Biotechnology Co do? GeneFerm Biotechnology Co Ltd is a company based in Tainan, Taiwan, operating within the Consumer Staples sector and the Consumer products industry. It went public on July 26, 2016, with the ticker symbol 1796.TWO and ISIN TW0001796001. The company focuses on the manufacture and sale of health food and dietary supplements. Its product portfolio includes fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrates. GeneFerm also offers related manufacturing services, as well as health food design, research, and development services. The company's headquarters are located in Tainan, Taiwan, and it maintains a website at https://www.geneferm.com/. As a publicly traded entity, GeneFerm Biotechnology Co Ltd is listed on the Taiwan Stock Exchange, providing investors with access to its financial performance and corporate activities. The company's operations are centered around the development and production of health-focused food and supplement products, emphasizing natural and fermented ingredients. Its services extend beyond product manufacturing to include design, R&D, and manufacturing support for health food solutions. The firm has been active in the market since its IPO in 2016, contributing to the consumer staples sector with its specialized health food offerings. GeneFerm Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

PEG Ratio (Price/Earnings-to-Growth) of GeneFerm Biotechnology Co is 0.19 in 2025.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) GeneFerm Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s GeneFerm Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — GeneFerm Biotechnology Co

All Key Metrics — GeneFerm Biotechnology Co